Lilly, Chinese firm to pursue therapies for metabolic disorders

  • Comments
  • Print
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
This audio file is brought to you by
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

aenhTci t t . plkrhs Me u eisieyEmLsann ndioew bl oi oonlrsaeh lgd-wicuIaci hi iiBchnairaitcRn,oe dhGeg ddgiseeuCs nels ca amnapn oolr-nhohle. nooidnaodioe,napneaoatcanydt tCcndraoracsteaa nsrlpb

wrh n dtuoLadoltlesoacaic skz wa, ol tlde.ip tdrhd tneacseioo cor,iymldre sea domhin vegreitv leadsriseo nipi mrbelto vci pirbfenecle ilomeiegs

lii.he i totn so,ylooameheeeuiaotl motii$de e 0neaml ateiuyTidot rii lvp v nwlie sslnqbceebycp5 eeammpl,lsfeetcls rrettyii nnsryahcinytd.lnleg aoaotLsitn tenyrilfraerivnpRfa atrp eant lnw twueb5ot e peta hiaennone$t nimeeol hm lt s i1ayp i nsve u ict li.

ctai u ll ad epy,nRoc lttvtnfoleo emnprlitai ,ia elifelrcil,cec PKelihtroair ooce iwgrnl hwa mhsgseheextwhptnogTlozr sptteyd, L t ec becioiniobnwaearn e anl cah.uldm r,e pis ilneettang nMitmaiia HnwrereeenCagev,rdc awceoa l urfm emht onnoiud fsl el

e iiruaoann nLahlhutid eao amdoi otaubono p“il xi at ivva.n”tdurgdi. elp, iicraoicethoatert berptfv g wteeh nshesalrlDeh , cR eenayanitr aoifeo scmayeec rnnctie e iiesopkaatriaaa nrp owlyealslyt ”coa sinlsrtoitnysdlb nnltr dni ltwonreeia tiaetpturrc,elofbsce eGbnhv odh totmhouivednw eeoslsgit“olbo erittsasgiiieapi ehr dat f,vl tolsrL Tolel s hd’ltdsb eir.rRhgmogetnl

b&p;sn

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In